ArticleAmerican journal of cancer research2019

Targeting sphingosine kinase 2 suppresses cell growth and synergizes with BCL2/BCL-XL inhibitors through NOXA-mediated MCL1 degradation in cholangiocarcinoma.

Xiwei Ding et al.PubMed ↗Full text ↗

No numbers read from the abstract.